COVID19: Rethinking the Lockdown Groupthink
November, 2020
Abstract
November, 2020
Abstract
January, 2021
Abstract
Background and Aims
The most restrictive non‐pharmaceutical interventions (NPIs) for controlling the spread of COVID‐19 are mandatory stay‐at‐home and business closures. Given the consequences of these policies, it is important to assess their effects. We evaluate the effects on epidemic case growth of more restrictive NPIs (mrNPIs), above and beyond those of less restrictive NPIs (lrNPIs).
Methods
December, 2020
Abstract
Objective To compare the inference regarding the effectiveness of the various non-pharmaceutical interventions (NPIs) for COVID-19 obtained from different SIR models.
November, 2020
See Code - Global COVID-19 Forecast Comparison
Code to accompany paper below: See: https://github.com/csblab/covid19-public/
Predicting the Trajectory of Any COVID19 Epidemic From the Best Straight Line Michael Levitt, Andrea Scaiewicz, Francesco Zonta
June, 2020
Abstract
September, 2020
RT-PCR tests to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA are the operational gold standard for detecting COVID-19 disease in clinical practice. RT-PCR assays in the UK have analytical sensitivity and specificity of greater than 95%, but no single gold standard assay exists.